- Investing Ideas
- /
- Chinese Too Big To Fail
Chinese Too Big To Fail
Results
46
Large established companies which pay a dividend.
46 companies
Livzon Pharmaceutical Group
Market Cap: CN¥33.9b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
000513
CN¥40.32
7D
-0.7%
1Y
14.2%
Xiamen C&D
Market Cap: CN¥31.6b
Engages in the supply chain and real estate development businesses in China and internationally.
600153
CN¥10.90
7D
1.9%
1Y
45.7%
Yunnan Chihong Zinc & Germanium
Market Cap: CN¥31.4b
Yunnan Chihong Zinc & Germanium Co., Ltd.
600497
CN¥6.22
7D
0.5%
1Y
35.2%
Yifeng Pharmacy Chain
Market Cap: CN¥31.3b
Engages in the retail business of pharmaceutical products in China.
603939
CN¥25.84
7D
-0.2%
1Y
45.6%
Wangsu Science & TechnologyLtd
Market Cap: CN¥28.0b
Provides information infrastructure platform services worldwide.
300017
CN¥11.45
7D
4.9%
1Y
75.3%
Shanghai M&G Stationery
Market Cap: CN¥27.2b
Provides writing tools, student stationery, office stationery, and other related products in China and internationally.
603899
CN¥29.55
7D
-3.7%
1Y
15.9%
Hisense Visual Technology
Market Cap: CN¥26.6b
Engages in the research and development, production, and sales of display chips and products in China and internationally.
600060
CN¥20.78
7D
-5.0%
1Y
33.3%
Loncin Motor
Market Cap: CN¥25.0b
Manufactures and sells generating sets, agricultural machinery equipment, light-duty power units, and two-wheeled motorcycles in Japan and internationally.
603766
CN¥12.17
7D
-4.8%
1Y
76.9%
Songcheng Performance DevelopmentLtd
Market Cap: CN¥24.5b
Operates in the performing arts industry primarily in China.
300144
CN¥9.36
7D
3.7%
1Y
31.3%
Tasly Pharmaceutical Group
Market Cap: CN¥23.9b
Engages in the pharmaceutical business in China and internationally.
600535
CN¥15.98
7D
-2.1%
1Y
16.0%